Mealey's ( August 22, 2017, 12:59 PM EDT) -- JACKSON, Miss. — A Mississippi federal jury on Aug. 18 returned a defense verdict in the third Xarelto bleeding trial, finding that defendants Janssen Research & Development LLC and Bayer Healthcare Pharmaceuticals Inc. did not fail to adequately warn the plaintiff’s doctor about the safe use of the anticoagulant and did not defectively design the drug (In Re: Xarelto [Rivaroxaban] Products Liability Litigation, No. 14-md-2592, Dora Mingo v. Janssen Research & Development, LLC, et al., No. 15-3469, E.D. La.)....